Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DN2Z5C
|
|||
| Drug Name |
LABP-104
|
|||
| Synonyms |
NIM-1324
Click to Show/Hide
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20; ICD-9: 729] | Phase 1 | [1] | |
| Company |
Landos Biopharma Blacksburg, VA
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | LanC-like protein 2 (LANCL2) | Target Info | Agonist | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05019950) A Randomized, Placebo-Controlled, Double-Blind, Single-Center Study to Evaluate Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers. U.S.National Institutes of Health. | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.